Aloe vera in the treatment for oral submucous fibrosis - a preliminary study

Journal of Oral Pathology and Medicine

Volumn 41, Issue 10, 2012, Pages 755-761

  Sudarshan, Ramachandran ^a   Annigeri, Rajeshwari G ^b   Vijayabala, Sree ^c  

^a Sibar Institute of Dental Sciences ^*  (India)

^b Davangere   (India)

^c Thai Moogambikai Dental College and Hospital ^*  (India)

Author keywords

Aloe vera; Antioxidants; Oral submucous fibrosis

Indexed keywords

ALOE VERA EXTRACT; ANTIOXIDANT;

ADOLESCENT; ADULT; ALOE VERA; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MOUTH DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ALOE; ANTIOXIDANTS; FEMALE; GELS; HUMANS; MALE; ORAL SUBMUCOUS FIBROSIS; PHYTOTHERAPY; PLANT EXTRACTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868374027     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01168.x     Document Type: Article

References (40)

1. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36: 575-80.
2. Shah N, Sharma PP. Role of chewing and smoking habits in the etiology of OSMF: a case control study. J Oral Pathol Med 1998; 27: 475-9.
3. Auluck A, Rosin MP, Zhang L, Sumanth KN. Oral Submucous Fibrosis, a Clinically Benign but Potentially Malignant Disease: report of 3 Cases and Review of the Literature. J Can Dent Assoc 2008; 74: 735-40.
4. Subapriya R, Kumaraguruparan R, Nagini S, Thangavelu A. Oxidant-antioxidant status in oral precancer and oral cancer patients. Toxicol Mech Methods 2003; 13: 77-81.
5. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 1985; 13: 340-1.
6. Das AD, Balan A, Sreelatha KT. Comparative Study of the Efficacy of Curcumin and Turmeric Oil as Chemopreventive Agents in Oral Submucous Fibrosis: a Clinical and Histopathological Evaluation. JIAOMR 2010; 22: 88-92.
7. Mathur RM, Jha T. Normal oral flexibility a guideline for OSMF cases. J Indian Dent Assoc 1993; 64: 139-43.
8. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966; 22: 764-9.
9. Phatak AG. Fibrin producing factor in oral submucous fibrosis. Indian J Orolaryngol 1979; 31: 103-4.
10. Ahmad MS, Ali SA, Ali AS, Chaubey KK. Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India. J Indian Soc Pedod Prev Dent 2006; 24: 84-9.
11. Gupta SC, Yadav YC. "MISI" an etiologic factor in oral submucous fibrosis. Indian J Otolaryngol 1978; 30: 5-6.
12. Prabhu SR, et al. Oral disease in the tropics. Delhi: Oxford University Press, 1993; 417-22.
13. Dorle RM, Jagtap MW. Estimation of complement C3 in oral submucous fibrosis. Int J Oral Maxillofac Surg 1987; 16: 753-6.
14. Adhvaryu SG, Bhatt RG, Dayal PK, et al. SCE frequencies in lymphocytes of tobaccobetel nut chewers and patients with oral submucous fibrosis. Br J Cancer 1986; 53: 141-3.
15. Canniff JP, Batchelor JR, Dodi IA, Harvey W. HLA-typing in oral submucous fibrosis. Tissue Antigens 1985; 26: 138-42.
16. Phatak AG. Hypercoagulation and fibrinolysis in oral submucous fibrosis. Am J Clin Pathol 1984; 81: 623-8.
17. Rajendran R, Sugathan CK, Remani P, Ankathil R, Vijayakumar T. Cell mediated and humoral immune responses in oral submucous fibrosis. Cancer 1986; 58: 2628.
18. Jalouli J, Ibrahim SO, Mehrotra R, et al. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 2010; 130: 1306-11.
19. Ipe V, Rajendran R, Sugathan CK, Vijayakumar T. Prevalence of oralsubmucous fibrosis among the cashew workers of Kerala South India. Indian J Cancer 1986; 23: 101-4.
20. Rajendran R, Raju GK, Nair SM, Balasubramanian G. Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, South India. Bull WHO 1992; 70: 783-9.
21. Trivedy CR, Warnakulasuriya KA, Peters TJ, Senkus R, Hazarey VK, Johnson NW. Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 2000; 29: 241-8.
22. Gupta D, Sharma SC. Oral submucous fibrosis - a new treatment regimen. J Oral Maxillofac Surg 1988; 46: 830-3.
23. Khanna JN, Andrade NN. Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases. Int J Oral Maxillofac Surg 1995; 24: 433-9.
24. Haque MF, Meghji S, Nazir R, Harris M. Interferon gamma (IFN-γ) may reverse oral submucous fibrosis. J Oral Pathol Med 2001; 30: 12-21.
25. Lin HJ, Lin JC. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function. Oral Dis 2007; 13: 407-13.
26. Sharma JK, Gupta AK, Mukhija RD, Nigam P. Clinical experience with the use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 1987; 16: 695-9.
27. Rajendran R, Rani V, Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res 2006; 17: 190-8.
28. Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chiang CP. Oral administration from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 2001; 30: 618-25.
29. Hastak K, Lubri N, Jakhi SD, et al. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett 1997; 116: 265-9.
30. Kumar A, Bagewadi A, Keluskar V, Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 207-13.
31. Rao B. Oral submucous fibrosis - the Davangere Study. JIAOMR 1993; 4: 11-22.
32. Gupta S, Reddi MVR, Harinath BC. Role of oxidative stress and antioxidants in etiopathogenesis and management of oral submucous fibrosis. Indian J Clin Biochem 2004; 19: 138-41.
33. Gupta DS, Gupta MK, Golhar BL. Oral submucous fibrosis - a clinical study and management by physiofibrolysis (MWD). J Indian Dent Assoc 1980; 52: 375-8.
34. Cox S, Zoellner H. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. J Oral Pathol Med 2009; 38: 220-6.
35. Sinor PN, Gupta PC, Murti PR, et al. A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 1990; 19: 94-8.
36. Pal P, Harman D, Sharma P, Verma N. Review: Antioxidant in oral health - Recent Scenario. JIAOMA 2004; 16: 119-28.
37. Borle RM, Borle SR. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991; 49: 788-91.
38. Sinha SN, Jain PK. Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis. Indian J Otolaryngol 1979; 31: 72-5.
39. Davis RN. Biological activity of Aloe Vera. Seifen Oele Fette Wachse 1993; 119: 646-9.
40. Kerr AR, Warnakulasuriya S, Mighell AJ, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis 2011; 17: 42-57.